GSK head joins Nabriva as chief medical officer
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elyse Seltzer, GSK, Nabriva Therapeutics
Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …
After the UK general election, what’s next for pharma?
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity
In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …
EMA recommends eight drugs for approval
May 22, 2015Sales and Marketing Amgen, BMS, EMA, Janssen, Merck, keytruda
The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha …
Bayer wins Cancer Drugs Fund appeal
May 22, 2015Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly
Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …
Sanofi’s rheumatoid arthritis biologic performs
May 22, 2015Sales and Marketing Sanofi, rheumatoid arthritis, sarilumab
French pharma giant Sanofi plans to submit its new rheumatoid arthritis biologic for regulatory approval in the US after it …
Boehringer and Eureka reach cancer antibodies deal
May 22, 2015Research and Development, Sales and Marketing Boehringer, eureka
Boehringer Ingelheim and Eureka Therapeutics have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology.No …
GW Pharma appoints president and moves CEO to US
May 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GW Pharmaceuticals, Julian Gangolli
US biopharma firm GW Pharmaceuticals has appointed Julian Gangolli as president of its North American division, and is also relocating its …
Analysts predict Pfizer to swallow GSK
May 21, 2015Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger
GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …
Pharma firm seeks judicial review against transparency
May 21, 2015Medical Communications, Research and Development, Sales and Marketing Richmond Pharmacology, hra, transparency
The battle for greater transparency in the pharma industry is to take another twist after a company lodged a legal …
J&J to file 10 new key drugs by 2019
May 21, 2015Sales and Marketing J&J, JJ
Johnson & Johnson says it plans to file 10 new products with regulators between 2015 and 2019 with each having …
Pfizer board member stepping down
May 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marc Tessier-Lavigne, Pfizer
Dr Marc Tessier-Lavigne is leaving Pfizer’s board of directors to work on the launch of Denali, a new biotech company …
Industry awaits key immunotherapy results at ASCO
May 20, 2015Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma
This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …
Scottish government doubles fund for new medicines
May 20, 2015Research and Development, Sales and Marketing Scotland, cystic fibrosis, medicines
The Scottish government will increase its New Medicines Fund next year to double the amount of money available to fund …
NHS online starting to take shape
May 20, 2015Medical Communications, Sales and Marketing HSCIC, NHS, brett wells, nhs online
In England over 55 million patients can now order repeat prescriptions, book GP appointments and access their medical records online …
Amgen hires senior VP, general counsel and secretary
May 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, jonathan graham
Amgen has appointed Jonathan Graham as its senior vice president, general counsel and secretary who will take to his post in July. …
Merck KGaA’s sales climb but key drugs fall
May 19, 2015Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif
Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …
Endo lands a big fish with $8 billion Par Pharma deal
May 19, 2015Sales and Marketing Endo, Valeant, par pharma
Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …
AstraZeneca building $285m biologics plant in Sweden
May 19, 2015Manufacturing and Production, Sales and Marketing AstraZeneca, Sweden, Södertälje, brett wells
AstraZeneca is spending around $285 million on a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The …
Pfizer head joins UK biotech Calchan
May 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, calhan, zahid ali
UK-based biotech Calchan has looked to Pfizer for appointing a new chief scientific officer in Zahid Ali. Ali has almost …
Cameron restates £8 billion NHS funding plans
May 18, 2015Sales and Marketing BMA, Cameron, NHS, UK
UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
